Immunicum’s vaccine INTUVAC is mentioned in Thomson Reuters
Immunicum vaccine INTUVAC is mentioned in Thomson Reuters’ “A Pharma Matters Report: THE ONES TO WATCH” as one of the most promising drugs to change clinical phase in Q1 2012. Read the report here.
Notice: Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /home/i/immunicu/www/wp-includes/functions.php on line 4805